News | Coronavirus (COVID-19) | April 03, 2020

COVID-19 STEMI Registry Created to Study Acute Cardiovascular Effects of the Virus

SCAI and CAIC announce the formation of the North American COVID-19 ST-Segment Elevation Myocardial Infarction Registry (NACMI)

CDC image of the novel coronavirus (COVID-10) SCAI and CAIC have created a registry to investigate the cardiovascular impact of the virus. #COVID19 #coronavirus #SARScov2

A CDC image of the novel coronavirus (COVID-10) SCAI and CAIC have created a registry to investigate the cardiovascular impact of the virus. 


April 3, 2020 — The Society for Cardiovascular Angiography and Interventions (SCAI) and the Canadian Association of Interventional Cardiology (CAIC) announced the formation of the North American COVID-19 ST-Segment Elevation Myocardial Infarction Registry (NACMI). This will record data on novel coronavirus (COVID-19, SARS-CoV-2) patients who have STEMI. The purpose of the trial is to quickly gather information to understand the adverse cardiovascular effects being seen in COVID-19 patients.

"We believe that this registry has the potential to provide critically important time-sensitive data to inform the management and treatment guidelines applicable to COVID-19 patients," SCAI said in a statement on the study.

Any COVID-19 positive patients or persons under investigation (PUI) with ST-segment elevation or new-onset left bundle branch block (LBBB) with a clinical correlate of myocardial ischemia (including chest pain, dyspnea, cardiac arrest, hemodynamic instability) will be in enrolled. The data will be compared to an age and gender-matched control population from the existing Midwest STEMI Consortium, which is a large (>15,000), prospective multi-center registry of consecutive STEMI patients. 

The study will be chaired by Tim Henry, M.D. from SCAI, Lindner Family Distinguished Chair in Clinical Research and medical drector of The Carl and Edyth Lindner Center for Research at The Christ Hospital, and Payam Dehghani, M.D., from CAIC, interventional cardiologist at Prairie Vascular Research Network in Regina, Canada.  The NACMI registry has pending U.S. FDA Institutional Review Boards (IRB) approval and will have an ECG and angiographic core lab. 

Interested sites can designate a local principal investigator and contact either SCAI PI Tim Henry ([email protected]), CAIC PI Payam Dehghani ([email protected]) or the data coordinating center ([email protected] or [email protected]) to obtain participating site information.

UPDATE Oct 14, 2020 - COVID-19 Positive STEMI Patients Have Higher Mortality ​​​, first data presented at TCT 2020 virtual meeting.​

Find more cardiology related COVID-19 news and video

 

Related Content

Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

Home October 29, 2021
Home
News | Cardiac Diagnostics

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used proprietary wearable cloth ...

Home October 04, 2021
Home
News | Cardiac Diagnostics

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

Home September 28, 2021
Home
News | Cardiac Diagnostics

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

Home July 29, 2021
Home
News | Cardiac Diagnostics

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
News | Cardiac Diagnostics

March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential ...

Home March 08, 2021
Home
News | Cardiac Diagnostics

March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...

Home March 03, 2021
Home
Subscribe Now